1. "2011"
Formats
  1. Journal Article (2141)
  2. Meeting Abstract (988)
  3. Book Section (224)
  4. Conference Paper (18)
  5. Book Whole (11)
Groups
  1. Department of Medicine (1176)
  2. Surgery (803)
  3. GSK Faculty (796)
  4. Solid Tumor Oncology Division (659)
  5. Sloan Kettering Institute Faculty (606)
  6. Survivorship Research (542)

More Groups

People
  1. Robert Soslow (64)
  2. Clifford Hudis (60)
  3. Mithat Gonen (54)
  4. Marc Ladanyi (52)
  5. Robert Motzer (52)
  6. Valerie Rusch (47)

More People

Years
  1. 2011 (3382)
Publications
  1. Journal of Clinical Oncology (319)
  2. Blood (147)
  3. Cancer Research (122)
  4. International Journal of Radiation Oncology, Biology, Physics (104)
  5. Modern Pathology (70)
  6. Laboratory Investigation (65)

More Publications

Publishers
  1. Elsevier Inc. (450)
  2. American Society of Clinical Oncology (327)
  3. Springer (231)
  4. American Association for Cancer Research (180)
  5. Nature Publishing Group (157)
  6. Wiley Blackwell (154)

More Publishers

Results (3382)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of ENMD-2076 in platinum-resistant ovarian cancer
    Meeting Abstract

    Matulonis, U.; Tew, W. P.; Matei, D.; Behbakht, K.; Fleming, G. F.; Oza, A. M.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Breast cancer phenotype in women with TP53 germ-line mutations: An LFS consortium effort
    Meeting Abstract

    Masciari, S.; Dillon, D.; Dick, M. G.; Robson, M. E.; Weitzel, J. N.; Ford, J. M.; Balmana, J.; Gruber, S. B.; Euhus, D.; Garber, J. E.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Combination of tivozanib (AV-951) with weekly paclitaxel for metastatic breast cancer: Results of a phase I study
    Meeting Abstract

    Mayer, E. L.; Scheulen, M. E.; Beckman, J.; Richly, H.; Poli, A.; Bhargava, P.; Duarte, A.; Cotreau, M. M.; Strahs, A. L.; Dickler, M. N.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A multicenter, open-label phase II trial of dovitinib (TKI258) in advanced urothelial carcinoma patients with either mutated or wild-type FGFR3
    Meeting Abstract

    Milowsky, M. I.; Carlson, G. L.; Shi, M. M.; Urbanowitz, G.; Zhang, Y.; Sternberg, C. N.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Is PET scan conversion from positive to negative a prognostic indicator for patients receiving therapy for unresectable liver metastases from colorectal carcinoma (CRC)?
    Meeting Abstract

    Maddox, G. J.; Chou, J. F.; Capanu, M.; Patel, D.; D'Angelica, M. I.; Kemeny, N. E.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Does the underlying etiology of HCC effect outcome? A single-institution analysis
    Meeting Abstract

    Ma, J.; Capanu, M.; O'Reilly, E. M.; Kemeny, N. E.; Ang, C.; Gansukh, B.; Kelsen, D. P.; Saltz, L.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Results of a study of the oral inhibitor PTC299 on tumor VEGF synthesis
    Meeting Abstract

    Luke, J. J.; Callahan, L. A.; Darby, C. H.; Winkelman, M. J.; Barth, J.; Elfring, G. L.; Ogden, A.; Schwartz, G. K.; Gounder, M. M.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Toward a rational strategy for prostate cancer screening based on long-term risk of prostate cancer metastases and death: Data from a large, unscreened, population-based cohort followed for up to 30 years
    Meeting Abstract

    Lilja, H.; Savage, C.; Gerdtsson, A.; Bjork, T.; Manjer, J.; Nilsson, P.; Dahlin, A.; Bjartell, A.; Scardino, P. T.; Ulmert, D.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Second-line therapy in follicular lymphoma in the United States: Report of NLCS observational study
    Meeting Abstract

    Link, B. K.; Miller, T. P.; Byrtek, M.; Cerhan, J. R.; Zelenetz, A. D.; Dillon, H.; Flowers, C.; Friedberg, J. W.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Effect of abiraterone acetate (AA) on pain control and skeletal-related events (SRE) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) post docetaxel (D): Results from the COU-AA-301 phase III study
    Meeting Abstract

    Logothetis, C.; De Bono, J. S.; Molina, A.; Basch, E. M.; Fizazi, K.; North, S. A.; Chi, K. N.; Jones, R. J.; Goodman, O. B.; Mainwaring, P. N.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save